$12M capital infusion pumps Prairie Village-based Artio Medical to $46M in funding
April 29, 2021 | Startland News Staff
A Johnson County medical device company announced Thursday the closing of an additional $12 million tranche of Series A financing — advancing the startup’s tech toward clinical study and commercialization with the backing of a leading Kansas City real estate developer.
“We are thrilled to close this round of financing with strong support from existing investors who share our mission to provide better patient outcomes,” said Dr. F. Nicholas Franano, president and CEO of Artio. “The Artio team is focused on the road ahead as we advance multiple development programs and prepare for commercialization of our first product.”
The funding brings Artio’s total capital raised to $46 million, Franano said.
Click here to see why Artio Medical, formerly also known as Metactive, was named one of Startland News’ Kansas City Startups to Watch in 2019.
Led by existing investors Sarah Hagedorn and Nathaniel Hagedorn — founder and CEO of Northpoint Development — the deal announced Thursday will be used to accelerate the development of Artio’s peripheral vascular product pipeline, which is highly complementary with significant overlap in call points and procedures, the company said.
The Amplifi Vein Dilation System, which aims to prepare hemodialysis patients for successful vascular access site creation, has shown promising results in initial clinical testing, Artio said in a press release. And the Solus Gold Embolization Device comprises a low-profile, flexible catheter assembly and a non-porous, gold balloon-like implant and is designed for precise placement and immediate vessel occlusion. The device has shown exceptional performance in preclinical testing, the company said.
“Nick has built a broad, diverse portfolio of highly innovative products at Artio and is assembling a world-class team to develop and commercialize them,” said Nathaniel Hagedorn. “We were pleased to have the opportunity to lead this round of financing and to invest additional capital to move the company and its mission forward.”
Just over a year ago, Artio announced its rebranding from “Metactive” and a fresh $8.8 million round to help boost its best-in-class products for the peripheral vascular and neurovascular markets.
Click here to learn more about Artio Medical.
Featured Business
2021 Startups to Watch
stats here
Related Posts on Startland News
A St. Joe CEO handed him a franchise after graduation; two years later, the risk is paying off
Spencer Engelman’s expectations for his post-college career were shredded by an offer he couldn’t refuse. The Northwest Missouri State University graduate was awarded a business of his own — minus the franchise fee — by a veteran entrepreneur who had visited one of his classes. “It’s a crazy opportunity,” said Engelman, who now operates a DocuLock…
What a catch: Kansas City fandom creates custom appeal for taco-loving cartoonist vibe
Drawing from Kansas City’s spotlight moments — whether trendy and new or iconic and timeless — W. Dave Keith balances a quirky aesthetic with a practical focus on what will actually sell. “I’ve slowly learned that if I want to make money off this business, I need to make stuff that people want to buy,”…
Power through purpose: How a winding journey led this eco devo steward to deep-rooted impact
Editor’s note: The following story was written and first published by the Economic Development Corporation of Kansas City, Missouri (EDCKC). Click here to read the original story. [divide] Going behind the scenes of CCED with the people who make it happen Some people are drawn to city-building because of the bricks and steel, the architecture, the skyline, the…
Missouri’s weapon in the AI race with China: KC tech companies, says GOP lawmaker
As artificial intelligence reshapes the way Kansas City works, civic and elected leaders want to ensure small businesses and the region’s tech community have seats at the table. Federal regulation could help, said Eric Schmitt. “For me, [it’s about] making sure that the big tech companies don’t block out a lot of the innovators, say…